Digital Pathology Market to Reach USD 17 Billion by 2030, Expanding at a CAGR of 12%
According to Next Move Strategy Consulting, the global Digital Pathology Market, is projected to grow to USD 17 billion by 2030, reflecting a compound annual growth rate (CAGR) of 12% during the forecast period by 2030. The growing prevalence of chronic diseases, the rising demand for rapid diagnostic tools, and the increasing trend of digitization in the medical sector are driving this remarkable growth.
Digital pathology—also referred to as digital imaging, virtual slides, or virtual microscopy—is an image-based environment that enables the procurement, management, and interpretation of pathological data using digital technology. This technology allows pathologists to digitize slides, analyze high-resolution images, and make accurate diagnoses, improving diagnostic accuracy and efficiency.
Download Free Sample: https://www.nextmsc.com/digital-pathology-market/request-sample
Key Drivers of Market Growth
The digital pathology market is largely driven by the increasing adoption of digital pathology for disease diagnosis, drug discovery, and research applications. The rising global burden of chronic diseases has amplified the demand for faster and more reliable diagnostic tools, positioning digital pathology as an essential technology. Additionally, the medical sector’s ongoing trend toward digitalization and the increasing government support for advanced healthcare technologies have further fueled the market's growth.
However, challenges such as high costs, lack of reimbursement models, and resistance from older pathologists to transition to new diagnostic tools are expected to hinder the market’s expansion. Despite these challenges, increasing awareness about the advantages of digital pathology and the introduction of affordable scanners for smaller practices are expected to create new growth opportunities.
Inquire Before Buying: https://www.nextmsc.com/digital-pathology-market/inquire-before-buying
Market Segmentation & Scope
The digital pathology market is segmented based on product type, application, end user, and geography:
- By Product: Scanners, software, and storage and communication systems
- By Type: Human and veterinary
- By Application: Teleconsultation, disease diagnosis, drug discovery, and training & education
- By End User: Educational, clinical, and pharmaceutical & biotech companies
- By Geography: North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
Geographical Insights
North America is expected to lead the market, driven by the adoption of advanced digital pathology technologies, high levels of R&D investment, and a strong presence of major market players. The Asia-Pacific region is forecasted to experience rapid growth, fueled by healthcare developments, the growing use of advanced imaging technologies, and increasing investment from multinational companies targeting untapped markets.
Competitive Landscape
The digital pathology market is highly competitive with the presence of major players such as Danaher Corporation, 3DHISTECH Ltd., Glencoe Software, Hamamatsu Photonics, Indica Labs, Koninklijke Philips, Nikon Corporation, PerkinElmer Inc., Roche, and Visiopharm A/S. Strategic initiatives like partnerships, acquisitions, and the development of new product offerings are driving market growth and consolidation.
For instance, in April 2019, HCG introduced the US FDA-approved digital pathology solution by Philips IntelliSite Pathology Solutions across all its centers in India, marking a significant step forward in cancer treatment with enhanced speed, precision, and efficiency.
Conclusion
The global digital pathology market is poised for robust growth due to technological advancements, the rising prevalence of chronic diseases, and the increasing demand for accurate and efficient diagnostic tools. With the continuous expansion of applications in disease diagnosis, drug discovery, and medical education, digital pathology presents significant opportunities for both healthcare providers and technology developers worldwide.
Also, Browse Related Reports:
For more information, please contact:
Next Move Strategy Consulting
E-Mail: info@nextmsc.com
Direct: +1-217-650-7991
Website: www.nextmsc.com
Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube
About Next Move Strategy Consulting:
Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.